Martin Shkreli

Daraprim Case: Martin Shkreli Invokes Fifth Amendment during Congressional Hearing

Former Turing Pharmaceuticals CEO Martin Shkreli refused to answer questions at a congressional hearing on the company's drug pricing policy.…

9 years ago

Daraprim Price: Martin Shkreli Asks for Immunity Before Congressional Hearing

Ex-Turing Pharmaceuticals CEO Martin Shkreli has asked for immunity in order to testify before a congressional hearing. Martin Shkreli was…

9 years ago

Daraprim: Turing to Cut HIV Drug Price for Some Users

Turing Pharmaceuticals, the company that sparked an outcry by raising the price of HIV drug Daraprim by 5,000%, says it…

9 years ago

Turing CEO Martin Shkreli Defends Decision to Raise Daraprim Price by 5,000%

Turing Pharmaceuticals CEO Martin Shkreli has defended his company's decision to raise the price of 62-year-old medication used by AIDS…

9 years ago